Gilead Sets Remdesivir Price, Commits Nearly All Near-Term Supplies To US

 
• By Mandy Jackson
  
Conceptual 3D illustration of two dials with needles pointing high value and low cost, horizontal image. Concept of business analysis
Gilead says its remdesivir price is well below the drug's cost-saving value • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip